Construction And Real Estate Tenders

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V for the Active Ingredient Finished Medicinal Product Smofkabiven, Atc B05ba10 for the Time 01.05.2025 - 30.04.2027

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V for the Active Ingredient Dupilumab, Atc D11ah05 for the Time 01.05.2025 - 30.04.2027

Completion of a Non-Exclusive Discount Agreement According to Section 130A (8) Sgb V for the Active Ingredient Peginterferon Beta-1A, Atc L03ab13 for the Time 01.05.2025-30.04.2027

Medicines Contracts with Accession Option

Framework contract tender for security services in Baden-Württemberg in three lots EnBW-2025-0015

Completion of a Non-Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Interferon Beta-1A (Excl. Intramuscular Injection), Atc L03ab07 for the Time 01.05.2025-30.04.2027

Open House Biologika Discount Contracts 2025-04-Follitropin Beta

Open Framework Agreement on Pharmaceutical Discounts in Accordance with Section 130A (8) Sgb V with any Time, So-Called Registration Model 2023-07

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Pimecrolimus, Atc D11ah02 for the Period 01.05.2025 - 30.04.2027

Open House Biologika Discount Contracts 2025-03-Interferon Beta-1A (Finished Medicinal Product Name: Avonex (R))